Esperite NV logo

ESP - Esperite NV Share Price

€0.026 -0.0  -6.4%

Last Trade - 9:56am

Sector
Healthcare
Size
Micro Cap
Market Cap £484k
Enterprise Value £2.99m
Revenue £12.2m
Position in Universe th / 854
Bullish
Bearish
Unlock ESP Revenue
Momentum
Relative Strength (%)
1m -4.47%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -80.0%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2012 2013 2014 2015 2016 2017 2018E 2019E CAGR / Avg
36.8 29.8 27.6 27.5 26.3 16.6 -14.8%
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the six months ended 30 June 2018, Esperite N.V. revenues decreased 36% to EUR5.3M. Net loss increased from EUR3M to EUR8.9M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Higher net loss reflects Finance Income decrease from EUR4M (income) to EUR2.5M (expense), General and administrative expenses increase of 12% to EUR5.5M (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

ESP Revenue Unlock ESP Revenue

Net Income

ESP Net Income Unlock ESP Revenue

Normalised EPS

ESP Normalised EPS Unlock ESP Revenue

PE Ratio Range

ESP PE Ratio Range Unlock ESP Revenue

Dividend Yield Range

ESP Dividend Yield Range Unlock ESP Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
ESP EPS Forecasts Unlock ESP Revenue
Profile Summary

Esperite NV is a company based in the Netherlands, which offers healthcare services. The Company operates a stem cell bank, as well as offers collection, analysis, processing and cryogenic preservation of three sources of human adult stem cells, namely hematopoietic stem cells obtained from the umbilical cord blood, mesenchymal stem cells obtained from the umbilical cord and mesenchymal stem cells obtained from adipose tissue. The Company’s Cryo-Save, as the international leading family stem cell bank, offers collection, analysis, processing and cryogenic preservation of three sources of human adult stem cells. The Company is active in over 70 countries on six continents. It operates processing and storage facilities in Belgium, Switzerland, Germany, Dubai, South Africa and Portugal.

Directors
Last Annual December 31st, 2017
Last Interim June 30th, 2018
Incorporated December 31, 2000
Public Since October 1, 2009
No. of Shareholders: n/a
No. of Employees: 205
Sector Healthcare
Industry Healthcare Providers & Services
Index
Exchange Euronext - Amsterdam
Shares in Issue 19,220,014
Free Float (0.0%)
Eligible for
ISAs
SIPPs
ESP Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for ESP
Upcoming Events for ESP
Frequently Asked Questions for Esperite NV
What is the Esperite NV share price?

As of 9:56am, shares in Esperite NV are trading at €0.026, giving the company a market capitalisation of £484k. This share price information is delayed by 15 minutes.

How has the Esperite NV share price performed this year?

Shares in Esperite NV are currently trading at €0.026 and the price has moved by -58.88% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Esperite NV price has moved by -56.36% over the past year.

What are the analyst and broker recommendations for Esperite NV?

Of the analysts with advisory recommendations for Esperite NV, there are there are currently "buy" , "hold" and "sell" recommendations. The overall consensus recommendation for Esperite NV is Not available. You can view the full broker recommendation list by unlocking its StockReport.

When will Esperite NV next release its financial results?

Esperite NV is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2019-06-30
What is the Esperite NV dividend yield?

Esperite NV does not currently pay a dividend.

Does Esperite NV pay a dividend?

Esperite NV does not currently pay a dividend.

When does Esperite NV next pay dividends?

Esperite NV does not currently pay a dividend.

How do I buy Esperite NV shares?

To buy shares in Esperite NV you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Esperite NV?

Shares in Esperite NV are currently trading at €0.026, giving the company a market capitalisation of £484k.

Where are Esperite NV shares listed? Where are Esperite NV shares listed?

Here are the trading details for Esperite NV:

Country of listing: Netherlands
Exchange: AEX
Ticker Symbol: ESP
What kind of share is Esperite NV?

We were not able to load our ranking data for Esperite NV

Is there a Esperite NV share price forecast 2020?

We were not able to load any forecast data for Esperite NV.

How can I tell whether the Esperite NV share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Esperite NV. Over the past six months, the relative strength of its shares against the market has been -29.49%. At the current price of €0.026, shares in Esperite NV are trading at -38.15% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Esperite NV PE Ratio?

We were not able to find PE ratio data for Esperite NV.

Who are the key directors of Esperite NV?

Esperite NV's management team is headed by:

Walter van Pottelberge - CHM
Ronald Lorijn - NED
Karin Dorrepaal - NED
Evi Mattil - CEO
Frederic Amar - CEO
Who are the major shareholders of Esperite NV?

Here are the top five shareholders of Esperite NV based on the size of their shareholding:

BofA Global Research (US) Research Firm
Percentage owned: 7.8% (4.08m shares)
Citadel Advisors LLC Hedge Fund
Percentage owned: 2.99% (1.57m shares)
L1 Capital Pty Ltd. Investment Advisor
Percentage owned: 0.94% (491k shares)
Similar to ESP
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.